GSK/BioNTech/Pfizer: Additional mRNA litigation
birdflustocks.com » bird flu stocks  »  GSK/BioNTech/Pfizer: Additional mRNA litigation
GSK/BioNTech/Pfizer: Additional mRNA litigation

Shortly after winning a stay on a COVID-19 vaccine patent lawsuit brought by Moderna, Pfizer and its German partner BioNTech are being dragged into another round of mRNA litigation by GSK.

https://www.fiercepharma.com/pharma/gsk-pulls-pfizer-and-biontech-another-vaccine-patent-lawsuit-time-surrounding-partners-mrna